September 2012 Volume 8, Issue 9
Volume 8, Issue 9 | September 2012
September 2012
In this Issue
Government Watch
Curing disease at the genetic level
European regulators poised to approve Western world’s first-ever gene therapy treatmentSecond verse, same as the first
ACLU and PUBPAT argue in vain in appeals court against patents on breast cancer genesStem cells can be regulated as drugs, court says
Judge sides with FDA in four-year battle over stem cell therapy use by Colorado companySun comes out for orphan diseases
FDA Safety and Innovation Act paves way for fast-tracking new treatments for rare conditionsResearch & Development
Disease in a dish
NYSCF research programs skin cells into Alzheimer’s disease brain cellsLooking to build a bit of synergy
Synergy Pharmaceuticals to formally merge with Callisto PharmaceuticalsT cell targets
Brigham and Women’s Hospital and Sanofi collaborate on immunomodulation of type 1 diabetesStem cells on the brain
Duke to examine Cytomedix stem cell treatment for glioma patientsAttention to detail
P2D Biosience, Advinus Therapeutics to develop unique therapies for ADHDTools & Technology
Tiny brain, huge potential
Vanderbilt University-led team to develop ‘microbrain’ to improve drug testingAstraZeneca goes virtual
Virtual lab from Assay Depot enables full project tracking via computerOne byte at a time
MSU researchers develop new computational technique to manage massive amounts of data on microbesA multiplex menu
Bio-Rad and Myriad RBM partner to commercialize multiplex biomarker kitsA pair for the win
Waters Corp. and Nonlinear Dynamics combine analytical science and informatics skills to advance proteomics and metabolomics researchDiagnostics
Change of Life
Life Technologies acquires Pinpoint Genomics and CLIA-approved lung cancer testHigh risk, high payoff
Metabolon, Lipomics Technologies combine forces to fight obesity, cancerA partnership with a firm Foundation
Foundation, Clovis to develop in-vitro diagnostic for PARP inhibitorFrom under the sea
Myriad Genetics and Pharma Mar ink companion diagnostic agreementGenMark goes ALL-digital
GenMark Diagnostics and Advanced Liquid Logic to develop an all-digital fully integrated diagnostic platformEditor's Focus
Genetic therapies? The heck, you say!
Gene therapies have been somewhat of an urban legend in the pharma/biotech industries for almost as long as I have been alive. Despite how far we’ve come and how far we’ve yet to go, we’re reporting some stories this month that suggest genetic medicine may not be as science fiction-y as it seems.Commentary
Out of Order: If you build it …
Where companies traditionally have had to jump through hoops to impress regulators to approve the drugs they develop, they will increasingly find themselves jumping through even narrower hoops to convince payors that they have made significant strides in improving patient care.Working together to eradicate cell line misidentification and contamination: New practices and policy
The consequences of using unauthenticated cell lines are already being brought to bear on researchers.CDx, cancer and collaborations: Take our reader survey
Drug Discovery News, in collaboration with investment bank Mizuho Securities USA Inc., is conducting a survey on the state of funding and views on companion diagnostics, oncology and pharma.Global News
Synergy among neighbors
Quintiles acquires Expression Analysis to advance safety, efficacy and value of personalized medicineLonza announces license agreement with iPS Academia Japan
Company adds iPSC line to its portfolio of cell therapy products and servicesCalling the X-MAN to battle cancer gene
Horizon Discovery and Domainex to explore lead molecules against TBK1/IKKeAll systems Funxional
Boehringer Ingelheim acquires Funxional’s somatotaxin anti-inflammatory programOmics & Systems Biology
Circuit-makers target genetic bottlenecks
MIT researchers build a ‘toolbox’ for synthetic biology to help control novel genetic circuits in cellsStudy unveils genetic underpinnings of PTSD
BUSM/VA Boston Healthcare System investigators identify new gene linked to post-traumatic stress disorderClosing the circle on Huntington’s disease
Thomson Reuters to collaborate with the CHDI Foundation to develop new tools to battle Huntington’s diseaseGoing after GPCR
Anchor Therapeutics collaborates with Kyowa Hakko Kirin for pepducin R&DFeature
Meeting of the minds
Neuroscience 2012 offers five days of cutting-edge research, networking, career opportunities and more in New Orleans
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
SubscribeSponsored
Harnessing liver-on-a-chip models for drug safety
Discover how researchers leverage microphysiological systems in toxicology studies.
Enhancing bioanalytical studies with centralized data management
Learn how researchers can improve compliance and efficiency with advanced LIMS solutions.
Explained: How are metabolite biomarkers improving drug discovery and development?
By offering a rich source of insights into disease and drugs, metabolite biomarkers are at the forefront of therapeutic exploration.
